As the world's largest biotechnology company, Amgen leverages innovative science and unique discoveries in molecular biology to create many of the most effective treatments for people fighting cancer. We constantly strive to extend the frontiers of cancer research and treatment.

Amgen has pioneered the development of novel products based on advances in recombinant DNA and molecular biology. To sustain our success, we aim to attract and retain the most talented people worldwide who are dedicated to our mission of serving patients. Together, we create innovative, best-in-class therapeutics that dramatically improve people’s lives.

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives. As part of our commitment, we founded The Amgen Oncology Institute, which provides educational grant support to the many people and organizations committed to accelerating the pace of scientific discovery, promoting awareness, and improving the quality of patients' lives.

For more than 25 years, Amgen scientists have applied innovative research to advance important new therapies for grievous illnesses. Amgen’s heritage lies in leading-edge molecular biology. This basic science platform permitted the development of protein therapeutics that have transformed the management of anemia, inflammation, and cancer.